Introduction: Why NAD+ Became the Symbol of Anti-Aging
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme present in every living cell. It participates in over 500 enzymatic reactions, including oxidative phosphorylation, DNA repair, and epigenome regulation. Massudi et al. (2012, PLoS ONE) found that skin NAD+ levels fall steadily with age (49 people aged 0–77).
This decline is associated with mitochondrial dysfunction, impaired DNA repair, chronic inflammation (inflammaging), and epigenetic drift — key hallmarks of aging described in the landmark paper by Lopez-Otin et al. in Cell (2013, updated 2023).
NAD+/NADH: Molecular Fundamentals
NAD+ exists in two forms: oxidized (NAD+) and reduced (NADH). The NAD+/NADH ratio is critical for metabolism: a high ratio (more NAD+) is associated with catabolism, fatty acid oxidation, and sirtuin activation. A low ratio (more NADH) signals anabolism and reduced cellular stress resilience.
NAD+ is synthesized through three pathways: de novo (from tryptophan), the salvage pathway (from nicotinamide via NAMPT), and the Preiss-Handler pathway (from nicotinic acid). The salvage pathway provides approximately 80% of cellular NAD+ and is the primary therapeutic target.
Sirtuins (SIRT1-7): Guardians of the Genome
Sirtuins are a family of NAD+-dependent deacetylases that play key roles in aging regulation. SIRT1 deacetylates histones and transcription factors (p53, FOXO, NF-kB), suppressing inflammation and activating DNA repair. SIRT3 is a mitochondrial sirtuin regulating beta-oxidation and antioxidant defense through SOD2.
A study in Nature (2013) showed that increasing SIRT1 activity in mice extends healthspan and improves metabolic parameters. SIRT6 is involved in telomere homeostasis, and its deficiency causes premature aging. All sirtuins are absolutely dependent on NAD+ — without it, their activity is impossible.
NMN vs NR: Which to Choose?
NMN (nicotinamide mononucleotide) is a direct NAD+ precursor requiring one enzymatic step for conversion (via NMNAT). Yoshino et al. (2021, Science) demonstrated that 250 mg NMN daily for 10 weeks raises NAD+ in blood cells and improves muscle insulin sensitivity in overweight postmenopausal women with prediabetes.
NR (nicotinamide riboside) is also a NAD+ precursor but requires two enzymatic steps (NRK to NMN to NAD+). Martens et al. (2018, Nature Communications) showed that 1000 mg NR (NIAGEN) daily for 6 weeks increases NAD+ by 60% in healthy older adults.
Comparison:
- NMN: 250-500 mg/day, rapid conversion, good storage stability
- NR: 300-1000 mg/day, longer research history, patented (NIAGEN)
- Both forms effectively raise NAD+; no clinical superiority of one over the other has been established
| Form | Dose | Note |
|---|---|---|
| NMN | 250–500 mg/day | rapid conversion |
| NR | 300–1000 mg/day | patented (NIAGEN) |
Pharmacokinetics of NAD+ Precursors
Single oral doses of NMN (100, 250 and 500 mg) in 10 healthy men caused no significant symptoms or changes in clinical parameters, and plasma nicotinamide metabolites rose dose-dependently [PMID 31685720]. In a 60-day RCT in 80 healthy middle-aged adults, blood NAD+ rose in all NMN groups (300, 600 and 900 mg/day) by day 30, most of all at 600 and 900 mg; tolerability was good at doses up to 900 mg/day [PMID 36482258]. In a 12-week RCT in 36 healthy middle-aged people, NMN 250 mg/day (125 mg twice daily) raised serum nicotinamide, one of the NAD+ metabolites; arterial stiffness tended to fall but did not differ significantly from placebo [PMID 36797393].
In 12 older men, 1 g of NR a day for 21 days raised NAD+ metabolites in skeletal muscle and lowered circulating inflammatory cytokines without changing mitochondrial bioenergetics [PMID 31412242].
IV NAD+ and NAD+ Biopellets: Advanced Methods
Intravenous NAD+ infusion (250-750 mg over 2-4 hours) provides 100% bioavailability, bypassing the GI tract. Clinical observations report rapid improvement in energy and cognitive function, but large RCTs are lacking. Common side effects include nausea, chest discomfort, and flushing during infusion.
NAD+ biopellets (subcutaneous pellets) are implantable capsules with slow NAD+ release, providing stable levels over several months. The method is evolving but lacks large-scale clinical data.
Epigenetic Clocks and NAD+
Epigenetic clocks (Horvath clock, GrimAge, DunedinPACE) measure biological age through DNA methylation patterns. A study in Aging Cell (2022) showed that raising NAD+ through NMN supplementation is associated with slower epigenetic aging, though large-scale RCTs using epigenetic clocks as a primary endpoint are pending.
David Sinclair at Harvard is the most prominent NAD+ and aging researcher. His lab demonstrated in Cell (2013) that boosting NAD+ through NMN reverses age-related mitochondrial decline in mice. However, translating results from mouse models to humans requires caution.
CD38: The Main Consumer of NAD+
CD38 is an ectoenzyme that actively breaks down NAD+, especially in immune cells. CD38 expression rises with age and with chronic inflammation, which is one of the reasons NAD+ declines with age.
Healthspan and Lifespan: Telling the Terms Apart
“Healthspan” (the years lived in good health) is fundamentally different from “lifespan” (total length of life). The goal of modern anti-aging medicine is compression of morbidity: reaching old age without chronic disease, physical dependence or cognitive decline. NAD+ therapy targets healthspan specifically: more energy, mental clarity, physical endurance and metabolic flexibility. Expecting supplements to extend lifespan dramatically is unrealistic. Lifestyle (physical activity, diet, sleep, social ties, a sense of purpose) has a far greater effect than any supplement.
Other Strategies to Boost NAD+
Exercise is the most powerful natural NAD+ stimulator through AMPK activation and increased NAMPT expression. A study in Aging (2020) found a 127% rise in muscle NAD+ after 10 weeks of resistance training in untrained adults around 60.
Caloric restriction / intermittent fasting activates AMPK, which boosts NAMPT and increases NAD+ via the salvage pathway.
Nicotinamide (vitamin B3) is an inexpensive NAD+ precursor via the salvage pathway; how much it raises NAD+ in humans is poorly studied. Adults should not exceed 900 mg/day (EFSA tolerable upper intake level).
NAD+ Therapy Protocol
Basic protocol:
- NMN: 250-500 mg in the morning on empty stomach (sublingual or oral)
- Or NR: 300-500 mg in the morning
- Resveratrol: 500 mg with fatty food (SIRT1 activator)
- TMG (trimethylglycine): 500 mg (methyl group compensation)
Advanced protocol (under medical supervision):
- IV NAD+: 250 mg once every 2-4 weeks
- NMN: 500 mg/day orally between infusions
- Monitoring: blood NAD+ levels, epigenetic clocks every 6 months
Resveratrol as a Sirtuin Activator
Resveratrol, a polyphenol from red grapes, was one of the first sirtuin-activating compounds (STACs) identified. Howitz et al. (Nature, 2003) showed that resveratrol activates SIRT1 and extends lifespan in yeast.
Safety of Long-Term Use
Long-term human studies of NMN/NR are limited to 12–24 weeks. So far the safety profile is favourable: the main side effects are mild gastrointestinal symptoms, headache at the start of use and, rarely, flushing. It is important to take them with enough methyl donors (TMG, methylfolate, B12): the NAD+ salvage pathway requires methylation of nicotinamide for excretion.
Frequently Asked Questions
When should I expect results from NMN/NR?
Subjective energy improvement: 2-4 weeks. Biomarker changes: 6-12 weeks. Epigenetic age effects: 6-12 months.
Is there a risk of cancer stimulation?
Theoretical concern exists: cancer cells also need NAD+. The concern has experimental support: in a Nature Cell Biology study (2019), NMN given to mice with precancerous pancreatic lesions increased inflammation and accelerated progression to pancreatic cancer. Human data on this risk are lacking. NAD+ therapy is contraindicated in active cancer; with a history of cancer, only on an oncologist's decision.
Can NAD+ be raised through diet and exercise alone?
Yes, exercise and fasting are powerful stimulators. However, after age 40-50, declining NAMPT makes supplementation justified.
What is the difference between NAD+ and NADH supplements?
NADH is the reduced form. For anti-aging, it is important to raise NAD+ (the oxidized form), which activates sirtuins. NADH supplements are less effective for this purpose.
Which is better — NMN swallowed or sublingual?
Studies have not yet shown a clear difference. A sublingual form theoretically bypasses first-pass liver metabolism, but its actual bioavailability in humans has not been assessed under controlled conditions.
This article is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting any treatment protocol.
Source: NAD+ and Cellular Aging: What's Behind the Hype — universum.earth. md_pereligyn — Перелыгин Владимир Игоревич.
